Methionine synthase A2756G polymorphism may predict ulcerative colitis and methylenetetrahydrofolate reductase C677T pancolitis, in Central China

BMC Medical Genetics

Volumn 9, Issue , 2008, Pages

  Chen, Min ^a,b   Peyrin Biroulet, Laurent ^a,c   Xia, Bing ^b   Guéant Rodriguez, Rosa Maria ^a   Bronowicki, Jean Pierre ^a,c   Bigard, Marc André ^a,c   Guéant, Jean Louis ^a,c  

^a UNIVERSITÉ DE LORRAINE   (France)

^b WUHAN UNIVERSITY   (China)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ADENINE; ANTIBIOTIC AGENT; CYANOCOBALAMIN; CYTOSINE; FOLIC ACID; GUANINE; MESALAZINE; METHIONINE SYNTHASE; SALAZOSULFAPYRIDINE; STEROID; THYMINE; 5 METHYLTETRAHYDROFOLATE HOMOCYSTEINE METHYLTRANSFERASE; HOMOCYSTEINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ADULT; AGE; ARTICLE; CELL METABOLISM; CHINA; COLITIS; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; FOLIC ACID DEFICIENCY; GENDER; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC TRAIT; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREVALENCE; PROCTITIS; RISK ASSESSMENT; ULCERATIVE COLITIS; ALLELE; CASE CONTROL STUDY; ENZYMOLOGY; GENETIC POLYMORPHISM; GENETICS; METABOLISM; MIDDLE AGED; RISK FACTOR;

5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; ADULT; ALLELES; CASE-CONTROL STUDIES; CHINA; COLITIS, ULCERATIVE; FEMALE; GENE FREQUENCY; GENOTYPE; HOMOCYSTEINE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 51949094637     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-9-78     Document Type: Article

References (32)

1. Stipanuk MH Sulfur amino acid metabolism: Pathways for production and removal of homocysteine and cysteine Annu Rev Nutr 2004, 24:539-77 10.1146/annurev.nutr.24.012003.132418 15189131
2. Frosst P Blom HJ Milos R Goyette P Sheppard CA Matthews RG Boers GJH den Heijer M Kluitmans LAJ ven den Heuve LP Rozen R A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase Nat Genet 1995, 10:111-113 10.1038/ ng0595-111 7647779
3. Put van der NM Gabreels F Stevens EM Smeitink JA Trijbels FJ Eskes TK Heuvel van den LP Blom HJ A second common mutation in the methylenetetrahydrofolate reductase gene: An additional risk factor for neural-tube defects? Am J Hum Genet 1998, 62:1044-1051 1377082 9545395 10.1086/301825
4. Chen J Stampfer MJ Ma J Selhub J Malinow MR Hennekens CH Hunter DJ Influence of a methionine synthase (D919G) polymorphism on plasma homocysteine and folate levels and relation to risk of myocardial infarction Atherosclerosis 2001, 154:667-672 10.1016/ S0021-9150(00)00469-X 11257268
5. Leclerc D Wilson A Dumas R Gafuik C Song D Watkins D Heng HH Rommens JM Scherer SW Rosenblatt DS Gravel RA Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria Proc Natl Acad Sci USA 1998, 95:3059-3064 19694 9501215 10.1073/pnas.95.6.3059
6. Namour F Olivier J Abdelmouttaleb I Adjalla C Debard R Salvat C Guéant J Transcobalamin codon 259 polymorphism in HT-29 and Caco-2 cells and in Caucasians: Relation to transcobalamin and homocysteine concentration in blood Blood 2001, 97:1092-1098 10.1182/ blood.V97.4.1092 11159542
7. den Heijer M Rosendaal FR Blom HJ Gerrits WB Bos GM Hyperhomocysteinemia and venous thrombosis: A meta-analysis Thromb Haemost 1998, 80:874-877 9869152
8. Perry IJ Refsum H Morris RW Ebrahim SB Ueland PM Shaper AG Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men Lancet 1995, 346:1395-1398 10.1016/ S0140-6736(95)92407-8 7475822
9. Peyrin-Biroulet L Rodriguez-Guéant RM Chamaillard M Desreumaux P Xia B Bronowicki JP Bigard MA Guéant JL Vascular and Cellular Stress in Inflammatory Bowel Disease: Revisiting the Role of Homocysteine Am J Gastroenterol 2007, 102:1-8 10.1111/ j.1572-0241.2007.01170.x
10. Mahmud N Molloy A McPartlin J Corbally R Whitehead AS Scott JM Weir DG Increased prevalence of methylenetetrahydrofolate reductase C677T variant in patients with inflammatory bowel disease, and its clinical implications Gut 1999, 45:389-394 1727640 10446107
11. Papa A De Stefano V Danese S Chiusolo P Persichilli S Casorelli I Zappacosta B Giardina B Gasbarrini A Leone G Gasbarrini G Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease Am J Gastroenterol 2001, 96:2677-2682 10.1111/j.1572-0241.2001.04127.x 11569694
12. Romagnuolo J Fedorak RN Dias VC Bamforth F Teltscher M Hyperhomocysteinemia and inflammatory bowel disease: Prevalence and predictors in a cross-sectional study Am J Gastroenterol 2001, 96:2143-2149 10.1111/j.1572-0241.2001.03950.x 11467646
13. Portela E Lerias C Palmeiro A Homocysteine and MTHFR C677T variant in inflammatory bowel disease Gut 1999, 45(Suppl):A15
14. Guedon C Le Cam-Duchez V Lalaude O Ménard JF Lerebourgs E Borg JY Prothrombotic inherited abnormalities other than factor V Leiden mutation do not play a role in venous thrombosis in inflammatory bowel disease Am J Gastroenterol 2001, 96:1448-1454 11374681
15. Vecchi M Sacchi E Saibeni S Meucci G Tagliabue L Duca F De Franchis R Inflammatory bowel diseases are not associated with major hereditary conditions predisposing to thrombosis Dig Dis Sci 2000, 45:1465-1469 10.1023/A:1005541028045 10961731
16. Chen M Xia B Rodriguez-Gueant RM Bigard M Guéant JL Genotypes 677TT and 677CT+1298AC of methylenetetrahydrofolate reductase are associated with the severity of ulcerative colitis in central China Gut 2005, 54:733-734 1774509 15831933 10.1136/gut.2004.062539
17. Magro F Dinis-Ribeiro M Araujo FM Pereira P Fraga MC Cunha-Ribeiro LM Tomé-Ribeiro A High prevalence of combined thrombophilic abnormalities in patients with inflammatory bowel disease Eur J Gastroenterol Hepatol 2003, 15:1157-1163 10.1097/ 00042737-200311000-00002 14560147
18. Guéant-Rodriguez RM Guéant JL Debard R Thirion S Hong LX Bronowicki JP Namour F Chabi NW Sanni A Anello G Bosco P Romano C Amouzou E Arrieta HR Sanchez BE Romano A Herbeth B Guilland JC Mutchinick OM Prevalence of methylenetetrahydrofolate reductase 677T and 1298C alleles and folate status: A comparative study among Mexican, West African and West European populations Am J Clin Nutr 2006, 83:701-707 16522920
19. Guéant JL Chabi N Guéant-Rodriguez RM Mutchinick O Debard R Payet C Lu X Villaume C Bronowicki JP Quadros EV Sanni A Amouzou E Xia B Chen M Anello G Bosco P Romano C Arrieta HR Sanchez BE Romano A Herbeth B Anwar W Namour F Environmental influence on the world-wide prevalence of a 776C>G variant in the transcobalamin gene (TCN2) J Med Genet 2007, 44:363-7 10.1136/jmg.2006.048041 17220211
20. Satsangi J Silverberg MS Vermaire S Colombel JF The Montreal classification of inflammatory bowel disease: Controversies, consensus, and implications Gut 2006, 55:749-753 10.1136/gut.2005.082909 16698746
21. Ueland PM Hustad S Schneede J Refsum H Vollset SE Biological and clinical implications of the MTHFR C677T polymorphism Trends Pharmacol Sci 2001, 22:195-201 10.1016/S0165-6147(00)01675-8 11282420
22. Oz HS Chen TS McClain CJ de Villiers WJ Antioxidants as novel therapy in a murine model of colitis J Nutr Biochem 2005, 16:297-304 10.1016/ j.jnutbio.2004.09.007 15866230
23. Guéant JL Guéant-Rodriguez RM Anello G Bosco P brunaud L Romano C Ferri R Romano A Candito M Namour B Genetic determinants of folate and vitamin B12 metabolism: A common pathway in neural tube defect and Down syndrome? Clin Chem Lab Med 2003, 41:1473-1477 10.1515/ CCLM.2003.226 14656028
24. Lewis SJ Ebrahim S Smith GD Meta-analysis of MTHFR 677C→T polymorphism and coronary heart disease: Does totality of evidence support causal role for homocysteine and preventive potential of folate? Br Med J 2005, 10:1136
25. Bjerregaard LT Nederby NJ Fredholm L Brandskund I Munkholm P Hey H Hyperhomocysteinaemia, coagulation pathway activation and thrombophilia in patients with inflammatory bowel disease Scand J Gastroenterol 2002, 37:62-67 10.1080/003655202753387374 11843038
26. Peyrin-Biroulet L Guéant-Rodriguez RM Chen M Bronowicki JP Bigard MA Guéant JL Association of MTRR 66A > G Polymorphism With Superoxide Dismutase and Disease Activity in Patients With Crohn's Disease Am J Gastroenterol 2008, 103:399-406 10.1111/ j.1572-0241.2007.01573.x 17925002
27. Rogers EJ Chen S Chan A Folate deficiency and plasma homocysteine during increased oxidative stress N Engl J Med 2007, 357:421-2 10.1056/ NEJMc066569 17652662
28. Drzewoski J Gasiorowska A Małecka-Panas E Bald E Czupryniak L Plasma total homocysteine in the active stage of ulcerative colitis J Gastroenterol Hepatol 2006, 21:739-43 10.1111/j.1440-1746.2006.04255.x 16677162
29. Arenas M Simpson G Lewis CM Shobowale-Bakre el-M Escuredo E Fairbanks LD Duley JA Ansari A Sanderson JD Marinaki AM Genetic variation in the MTHFR gene influences thiopurine methyltransferase activity Clin Chem 2005, 51:2371-4 10.1373/clinchem.2005.053157 16306100
30. Cattaneo M Vecchi M Zighetti ML Saibeni S Martinelli I Omodei P Mannucci PM de Franchis R High prevalence of hyperhomocysteinemia in patients with inflammatory bowel disease: A pathogenic link with thromboembolic complications? Thromb Haemost 1998, 80:542-545 9798965
31. Oldenburg B Fijnheer R Griend van der R vanBerge-Henegouwen GP Koningsberger JC Homocysteine in inflammatory bowel disease: A risk factor for thromboembolic complications? Am J Gastroenterol 2000, 95:2825-2830 10.1111/j.1572-0241.2000.03193.x 11051355
32. Danese S Papa A Saibeni S Repici A Malesci A Vecchi M Inflammation and Coagulation in Inflammatory Bowel Disease: The Clot Thickens Am J Gastroenterol 2007, 102:174-186 10.1111/j.1572-0241.2006.00943.x 17100967